Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New study tracks safety of psychiatric drugs in pregnancy

NCT ID NCT01246765

First seen Oct 31, 2025 · Last updated Jun 23, 2026 · Updated 37 times

Summary

This registry aims to gather information on the safety of psychiatric medications taken during pregnancy, including antidepressants, ADHD drugs, and antipsychotics. Researchers will follow 5,000 pregnant women aged 18-45 and review infant health records for major birth defects. The goal is to fill current data gaps and help guide treatment decisions.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PREGNANT WOMEN are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Massachusetts General Hospital

    RECRUITING

    Boston, Massachusetts, 02114, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this registry could provide clearer safety information about psychiatric medication use during pregnancy, helping doctors and patients make informed decisions.

What could go wrong

This is an observational registry, not a controlled trial, so it cannot prove cause and effect. Results may take years and could be limited by self-reporting and other factors.

Conditions

The condition(s) this trial relates to.

attention deficit hyperactivity disorder, inattentive type

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.